Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018)

Change management in allergic rhinitis and asthma multimorbidity using mobile technology

Esben Eller (Medlem af forfattergruppering), Søren Pedersen (Medlem af forfattergruppering), MASK study group, MASK study group*

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

26 Downloads (Pure)

Resumé

Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline by using the best approach to integrated care pathways using mobile technology in patients with allergic rhinitis (AR) and asthma multimorbidity. The proposed next phase of ARIA is change management, with the aim of providing an active and healthy life to patients with rhinitis and to those with asthma multimorbidity across the lifecycle irrespective of their sex or socioeconomic status to reduce health and social inequities incurred by the disease. ARIA has followed the 8-step model of Kotter to assess and implement the effect of rhinitis on asthma multimorbidity and to propose multimorbid guidelines. A second change management strategy is proposed by ARIA Phase 4 to increase self-medication and shared decision making in rhinitis and asthma multimorbidity. An innovation of ARIA has been the development and validation of information technology evidence-based tools (Mobile Airways Sentinel Network [MASK]) that can inform patient decisions on the basis of a self-care plan proposed by the health care professional.

OriginalsprogEngelsk
TidsskriftJournal of Allergy and Clinical Immunology
Vol/bind143
Udgave nummer3
Sider (fra-til)864-879
ISSN0091-6749
DOI
StatusUdgivet - mar. 2019

Fingeraftryk

Comorbidity
Guidelines
Self Medication
Delivery of Health Care
Health

Citer dette

@article{d913f87964514f38914e3c198af7101a,
title = "Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology",
abstract = "Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline by using the best approach to integrated care pathways using mobile technology in patients with allergic rhinitis (AR) and asthma multimorbidity. The proposed next phase of ARIA is change management, with the aim of providing an active and healthy life to patients with rhinitis and to those with asthma multimorbidity across the lifecycle irrespective of their sex or socioeconomic status to reduce health and social inequities incurred by the disease. ARIA has followed the 8-step model of Kotter to assess and implement the effect of rhinitis on asthma multimorbidity and to propose multimorbid guidelines. A second change management strategy is proposed by ARIA Phase 4 to increase self-medication and shared decision making in rhinitis and asthma multimorbidity. An innovation of ARIA has been the development and validation of information technology evidence-based tools (Mobile Airways Sentinel Network [MASK]) that can inform patient decisions on the basis of a self-care plan proposed by the health care professional.",
keywords = "Allergic Rhinitis and Its Impact on Asthma, Change management, asthma, rhinitis",
author = "Jean Bousquet and Hellings, {Peter W} and Ioana Agache and Flore Amat and Isabella Annesi-Maesano and Ansotegui, {Ignacio J} and Anto, {Josep M} and Claus Bachert and Bateman, {Eric D} and Anna Bedbrook and Kazi Bennoor and Mickael Bewick and Carsten Bindslev-Jensen and Sinthia Bosnic-Anticevich and Isabelle Bosse and Jan Brozek and Luisa Brussino and Canonica, {Giorgio W} and Victoria Cardona and Thomas Casale and {Cepeda Sarabia}, {Alfonso M} and Chavannes, {Niels H} and Lorenzo Cecchi and {Correia de Sousa}, Jaime and Elisio Costa and Cruz, {Alvaro A} and Wienczyslawa Czarlewski and {De Carlo}, Giuseppe and {De Feo}, Giulia and Pascal Demoly and Philippe Devillier and Dykewicz, {Mark S} and Yehia El-Gamal and Esben Eller and Fonseca, {Joao A} and Jean-Fran{\cc}ois Fontaine and Fokkens, {Wytske J} and Maria-Antonieta Guzm{\'a}n and Tari Haahtela and Magdalena Illario and Juan-Carlos Ivancevich and Jocelyne Just and Igor Kaidashev and Musa Khaitov and Omer Kalayci and Thomas Keil and Ludger Klimek and Kowalski, {Marek L} and Piotr Kuna and Violeta Kvedariene and Esben Eller and S{\o}ren Pedersen and {MASK study group} and {MASK study group*}",
note = "Copyright {\circledC} 2018 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.",
year = "2019",
month = "3",
doi = "10.1016/j.jaci.2018.08.049",
language = "English",
volume = "143",
pages = "864--879",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby, Inc.",
number = "3",

}

Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018) : Change management in allergic rhinitis and asthma multimorbidity using mobile technology. / Eller, Esben (Medlem af forfattergruppering); Pedersen, Søren (Medlem af forfattergruppering); MASK study group; MASK study group*.

I: Journal of Allergy and Clinical Immunology, Bind 143, Nr. 3, 03.2019, s. 864-879.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018)

T2 - Change management in allergic rhinitis and asthma multimorbidity using mobile technology

AU - Bousquet, Jean

AU - Hellings, Peter W

AU - Agache, Ioana

AU - Amat, Flore

AU - Annesi-Maesano, Isabella

AU - Ansotegui, Ignacio J

AU - Anto, Josep M

AU - Bachert, Claus

AU - Bateman, Eric D

AU - Bedbrook, Anna

AU - Bennoor, Kazi

AU - Bewick, Mickael

AU - Bindslev-Jensen, Carsten

AU - Bosnic-Anticevich, Sinthia

AU - Bosse, Isabelle

AU - Brozek, Jan

AU - Brussino, Luisa

AU - Canonica, Giorgio W

AU - Cardona, Victoria

AU - Casale, Thomas

AU - Cepeda Sarabia, Alfonso M

AU - Chavannes, Niels H

AU - Cecchi, Lorenzo

AU - Correia de Sousa, Jaime

AU - Costa, Elisio

AU - Cruz, Alvaro A

AU - Czarlewski, Wienczyslawa

AU - De Carlo, Giuseppe

AU - De Feo, Giulia

AU - Demoly, Pascal

AU - Devillier, Philippe

AU - Dykewicz, Mark S

AU - El-Gamal, Yehia

AU - Eller, Esben

AU - Fonseca, Joao A

AU - Fontaine, Jean-François

AU - Fokkens, Wytske J

AU - Guzmán, Maria-Antonieta

AU - Haahtela, Tari

AU - Illario, Magdalena

AU - Ivancevich, Juan-Carlos

AU - Just, Jocelyne

AU - Kaidashev, Igor

AU - Khaitov, Musa

AU - Kalayci, Omer

AU - Keil, Thomas

AU - Klimek, Ludger

AU - Kowalski, Marek L

AU - Kuna, Piotr

AU - Kvedariene, Violeta

AU - MASK study group

AU - MASK study group

A2 - Eller, Esben

A2 - Pedersen, Søren

N1 - Copyright © 2018 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

PY - 2019/3

Y1 - 2019/3

N2 - Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline by using the best approach to integrated care pathways using mobile technology in patients with allergic rhinitis (AR) and asthma multimorbidity. The proposed next phase of ARIA is change management, with the aim of providing an active and healthy life to patients with rhinitis and to those with asthma multimorbidity across the lifecycle irrespective of their sex or socioeconomic status to reduce health and social inequities incurred by the disease. ARIA has followed the 8-step model of Kotter to assess and implement the effect of rhinitis on asthma multimorbidity and to propose multimorbid guidelines. A second change management strategy is proposed by ARIA Phase 4 to increase self-medication and shared decision making in rhinitis and asthma multimorbidity. An innovation of ARIA has been the development and validation of information technology evidence-based tools (Mobile Airways Sentinel Network [MASK]) that can inform patient decisions on the basis of a self-care plan proposed by the health care professional.

AB - Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline by using the best approach to integrated care pathways using mobile technology in patients with allergic rhinitis (AR) and asthma multimorbidity. The proposed next phase of ARIA is change management, with the aim of providing an active and healthy life to patients with rhinitis and to those with asthma multimorbidity across the lifecycle irrespective of their sex or socioeconomic status to reduce health and social inequities incurred by the disease. ARIA has followed the 8-step model of Kotter to assess and implement the effect of rhinitis on asthma multimorbidity and to propose multimorbid guidelines. A second change management strategy is proposed by ARIA Phase 4 to increase self-medication and shared decision making in rhinitis and asthma multimorbidity. An innovation of ARIA has been the development and validation of information technology evidence-based tools (Mobile Airways Sentinel Network [MASK]) that can inform patient decisions on the basis of a self-care plan proposed by the health care professional.

KW - Allergic Rhinitis and Its Impact on Asthma

KW - Change management

KW - asthma

KW - rhinitis

U2 - 10.1016/j.jaci.2018.08.049

DO - 10.1016/j.jaci.2018.08.049

M3 - Journal article

VL - 143

SP - 864

EP - 879

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 3

ER -